Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant humanized anti-HER2 monoclonal antibody |
|---|---|
| Date Designated: | 03/17/2025 |
| Orphan Designation: | treatment of gastric cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Shanghai Henlius Biotech, Inc. Room 901, 9th Floor, Building 1, No. 367 Shengrong Road China (Shanghai) Pilot Free Trade Zone Shanghai, Shanghai 201203 China The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







